Enrique Zudaire

Company: Janssen Research & Development

Job title: Senior Scientific Director Head of Cell Therapy, Oncology Translational Research

Seminars:

Exploring the Rational & Optimal Combinations 2:30 pm

Standardizing care: should we be more upfront with targeted therapies? Exploring optimal ways to treat & overcome toxicities Utilizing pre-clinical models to understand drug combinations and sequence Sharing insights on the different hypothesis made for different combinations BCMA CAR-T relapse, what’s next?Read more

day: Day Two

Panel Discussion:: The Differentiating Debate: On-The-Shelf vs Off-The Shelf 9:00 am

Dissecting the current state of accessibility What roles separate antibody-based and cell-based therapies – can they all live together? Discussing manufacturing production capabilities and scaling predictions for CAR-T: academic centers and community hospitals Exploring pricing: can profitability be demonstrated? Europe vs US vs global Understanding age group considerations How can we ensure timely CAR-T slot…Read more

day: Day Two